Study of Ultrasound-Guided Caudal Epidural Pulsed Radiofrequency to Treat Anal and Perineal Pain in Cancer Patients

What this Trial Is About

Researchers are evaluating the pain relief effects of ultrasound-assisted caudal epidural pulsed radiofrequency PRF stimulation in cancer patients experiencing anal or perineal pain. The study aims to measure pain levels using a visual analog scale VAS at baseline, and at two, four, and eight weeks after treatment. Secondary goals include assessing the impact on opioid use, quality of life, patient satisfaction, and any side effects related to opioids or the intervention. Participants will be randomly assigned to receive either the ultrasound-assisted caudal epidural pulsed radiofrequency procedure or conventional medical treatment without intervention. Those receiving the PRF procedure will be followed for up to eight weeks to monitor treatment effects and safety. The study does not use masking or blinding. During the study, participants will undergo pain assessments at multiple time points up to eight weeks post-intervention. Researchers will track opioid consumption, quality of life, patient satisfaction, and side effects related to both opioids and the treatment. The primary outcome focuses on the pain score at four weeks after treatment, with a final evaluation at eight weeks. Overall, participants will be monitored closely throughout the study period.

Efficacy of Ultrasound-assisted Caudal Epidural Pulsed Radiofrequency for Anal Pain in Cancer Patients,